A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Eli Lilly & Co has experienced a significant stock price drop of 10.58% over the past week, despite delivering impressive first-quarter results for 2025. The company’s revenue s ...

LEBANON, Ind. (WISH) — Gov. Mike Braun and Eli Lilly officials broke ground Tuesday on one of the first major projects for the LEAP District. Company officials said the Lilly Medicine Foundry ...

Eli Lilly is investing more in its home state of Indiana, pumping up to $250 million more into an existing collaboration with ...

Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

Eli Lilly stock has been a big-time winner over ... Beyond research and development (R&D), one of the major expense items for pharmaceutical companies is the cost of raw materials for making ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and ...

These developments may fuel Eli Lilly's projected annual revenue growth of 22.7% and possibly improve its profit margins despite potential challenges like pricing pressures and rising R&D costs.

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds industry ...

Eli Lilly (NYSE:LLY) experienced an 11% share price increase over the past month, largely influenced by the affirmation of a ...